de Boer RA - Search Results

1

Predictors and outcomes of heart failure with mid-range ejection fraction.

Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, de Filippi CR, Enserro D, Blaha MJ, Cushman M, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Brouwers FP, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Levy D, Herrington DM, van Gilst WH, Bertoni AG, Larson MG, de Boer RA, Gottdiener JS, Shah SJ, Ho JE. Bhambhani V, et al. Among authors: de filippi cr, de boer ra. Eur J Heart Fail. 2018 Apr;20(4):651-659. doi: 10.1002/ejhf.1091. Epub 2017 Dec 11. Eur J Heart Fail. 2018. PMID: 29226491 Free PMC article.

2

Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.

de Boer RA, van Geel PP, Pinto YM, Suurmeijer AJ, Crijns HJ, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. J Cardiovasc Pharmacol. 2002 Apr;39(4):610-9. doi: 10.1097/00005344-200204000-00017. J Cardiovasc Pharmacol. 2002. PMID: 11904535

3

Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.

de Boer RA, Pokharel S, Flesch M, van Kampen DA, Suurmeijer AJ, Boomsma F, van Gilst WH, van Veldhuisen DJ, Pinto YM. de Boer RA, et al. J Mol Med (Berl). 2004 Oct;82(10):678-87. doi: 10.1007/s00109-004-0579-3. Epub 2004 Aug 20. J Mol Med (Berl). 2004. PMID: 15322702

4

Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.

van der Meer P, Lipsic E, Henning RH, de Boer RA, Suurmeijer AJ, van Veldhuisen DJ, van Gilst WH. van der Meer P, et al. Among authors: de boer ra. Eur J Heart Fail. 2004 Dec;6(7):853-9. doi: 10.1016/j.ejheart.2004.03.012. Eur J Heart Fail. 2004. PMID: 15556046 Free article.

5

The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.

van der Meer P, De Boer RA, White HL, van der Steege G, Hall AS, Voors AA, van Veldhuisen DJ. van der Meer P, et al. Among authors: de boer ra. J Card Fail. 2005 May;11(4):279-84. doi: 10.1016/j.cardfail.2004.11.006. J Card Fail. 2005. PMID: 15880336 Clinical Trial.

6

Both antiplatelet and anticoagulant therapy may favorably affect outcome in patients with advanced heart failure. A retrospective analysis of the PRIME-II trial.

de Boer RA, Hillege HL, Tjeerdsma G, Verheugt FW, van Veldhuisen DJ. de Boer RA, et al. Thromb Res. 2005;116(4):279-85. doi: 10.1016/j.thromres.2004.12.008. Epub 2005 Jan 18. Thromb Res. 2005. PMID: 16038711 Clinical Trial.

7

A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.

Asselbergs FW, Moore JH, van den Berg MP, Rimm EB, de Boer RA, Dullaart RP, Navis G, van Gilst WH. Asselbergs FW, et al. Among authors: de boer ra. BMC Med Genet. 2006 Apr 19;7:39. doi: 10.1186/1471-2350-7-39. BMC Med Genet. 2006. PMID: 16623947 Free PMC article.

8

Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.

van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ; MERIT-HF Study Group. van der Harst P, et al. Among authors: de boer ra. J Am Coll Cardiol. 2007 Apr 3;49(13):1459-64. doi: 10.1016/j.jacc.2007.01.027. Epub 2007 Mar 21. J Am Coll Cardiol. 2007. PMID: 17397675 Free article.

9

Can critically short telomeres cause functional exhaustion of progenitor cells in postinfarction heart failure?

Oeseburg H, Westenbrink BD, de Boer RA, van Gilst WH, van Veldhuisen DJ, van der Harst P. Oeseburg H, et al. Among authors: de boer ra. J Am Coll Cardiol. 2007 Nov 6;50(19):1911-2; author reply 1912-3. doi: 10.1016/j.jacc.2007.07.055. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980263 Free article. No abstract available.

10

Anemia in chronic heart failure: etiology and treatment options.

Westenbrink BD, de Boer RA, Voors AA, van Gilst WH, van Veldhuisen DJ. Westenbrink BD, et al. Among authors: de boer ra. Curr Opin Cardiol. 2008 Mar;23(2):141-7. doi: 10.1097/HCO.0b013e3282f43025. Curr Opin Cardiol. 2008. PMID: 18303527 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

705 results

Search Page

Filters